These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23516174)

  • 21. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
    Carozzi F; Puliti D; Ocello C; Anastasio PS; Moliterni EA; Perinetti E; Serradell L; Burroni E; Confortini M; Mantellini P; Zappa M; Dominiak-Felden G
    BMC Infect Dis; 2018 Jan; 18(1):38. PubMed ID: 29334901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for human papillomavirus: is urine useful?
    D'Hauwers KW; Tjalma WA
    Indian J Cancer; 2009; 46(3):190-3. PubMed ID: 19574669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection and typing of human papillomavirus DNA in paired urine and cervical scrapes.
    Strauss S; Jordens JZ; McBride D; Sonnex C; Edwards S; Desselberger U; Watt P; Gray JJ
    Eur J Epidemiol; 1999 Jul; 15(6):537-43. PubMed ID: 10485346
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Final analysis of a study assessing genital human papillomavirus genoprevalence in young Australian women, following eight years of a national vaccination program.
    Garland SM; Cornall AM; Brotherton JML; Wark JD; Malloy MJ; Tabrizi SN;
    Vaccine; 2018 May; 36(23):3221-3230. PubMed ID: 29724506
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of human papillomavirus vaccination on racial/ethnic disparities in vaccine-type human papillomavirus prevalence among 14-26 year old females in the U.S.
    Hirth J; McGrath CJ; Kuo YF; Rupp RE; Starkey JM; Berenson AB
    Vaccine; 2018 Nov; 36(50):7682-7688. PubMed ID: 30377066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of human papillomavirus DNA in urine. A review of the literature.
    Vorsters A; Micalessi I; Bilcke J; Ieven M; Bogers J; Van Damme P
    Eur J Clin Microbiol Infect Dis; 2012 May; 31(5):627-40. PubMed ID: 21818524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of clinical performance of an ultrasensitive nanowire assay for detecting human papillomavirus DNA in urine.
    Lee H; Choi M; Jo M; Park EY; Hwang SH; Cho Y
    Gynecol Oncol; 2020 Mar; 156(3):641-646. PubMed ID: 31926639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monitoring the impact of HPV vaccine in males-Considerations and challenges.
    Brotherton JML; Giuliano AR; Markowitz LE; Dunne EF; Ogilvie GS
    Papillomavirus Res; 2016 Dec; 2():106-111. PubMed ID: 29074169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
    Chow EPF; Machalek DA; Tabrizi SN; Danielewski JA; Fehler G; Bradshaw CS; Garland SM; Chen MY; Fairley CK
    Lancet Infect Dis; 2017 Jan; 17(1):68-77. PubMed ID: 27282422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing genital human papillomavirus genoprevalence in young Australian women following the introduction of a national vaccination program.
    Osborne SL; Tabrizi SN; Brotherton JM; Cornall AM; Wark JD; Wrede CD; Jayasinghe Y; Gertig DM; Pitts MK; Garland SM;
    Vaccine; 2015 Jan; 33(1):201-8. PubMed ID: 25444787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Human Papillomavirus Detection in Urine and Cervical Samples Using High-Risk HPV DNA Testing in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Lekawanvijit S; Katruang N; Siriaunkgul S
    Obstet Gynecol Int; 2016; 2016():6801491. PubMed ID: 28101107
    [No Abstract]   [Full Text] [Related]  

  • 32. Human papillomavirus DNA in urine samples compared with that in simultaneously collected urethra and cervix samples.
    Forslund O; Hansson BG; Rymark P; Bjerre B
    J Clin Microbiol; 1993 Aug; 31(8):1975-9. PubMed ID: 8396581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus infection among young adolescents in India: impact of vaccination.
    Hussain S; Bharadwaj M; Nasare V; Kumari M; Sharma S; Hedau S; Das BC
    J Med Virol; 2012 Feb; 84(2):298-305. PubMed ID: 22170551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decline of HPV infections in Scandinavian cervical screening populations after introduction of HPV vaccination programs.
    Dillner J; Nygård M; Munk C; Hortlund M; Hansen BT; Lagheden C; Liaw KL; Kjaer SK
    Vaccine; 2018 Jun; 36(26):3820-3829. PubMed ID: 29778519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors.
    Damm O; Nocon M; Roll S; Vauth C; Willich S; Greiner W
    GMS Health Technol Assess; 2009 Mar; 5():Doc04. PubMed ID: 21289891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Knowledge about cervical cancer and HPV immunization dropout rate among Brazilian adolescent girls and their guardians.
    Santos ACDS; Silva NNT; Carneiro CM; Coura-Vital W; Lima AA
    BMC Public Health; 2020 Mar; 20(1):301. PubMed ID: 32143614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
    Poljak M; Seme K; Maver PJ; Kocjan BJ; Cuschieri KS; Rogovskaya SI; Arbyn M; Syrjänen S
    Vaccine; 2013 Dec; 31 Suppl 7():H59-70. PubMed ID: 24332298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of human papillomavirus (HPV) detection in urine and cervical swab samples using the HPV GenoArray Diagnostic assay.
    Nilyanimit P; Chansaenroj J; Karalak A; Laowahutanont P; Junyangdikul P; Poovorawan Y
    PeerJ; 2017; 5():e3910. PubMed ID: 29038761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.